Chemoinformaics analysis of (E)-Hexadec-11-en-1-ol
Molecular Weight | 240.431 | nRot | 13 |
Heavy Atom Molecular Weight | 208.175 | nRig | 1 |
Exact Molecular Weight | 240.245 | nRing | 0 |
Solubility: LogS | -1.84 | nHRing | 0 |
Solubility: LogP | 2.171 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 48.8594 |
nHD | 1 | BPOL | 32.1026 |
QED | 0.542 |
Synth | 1.909 |
Natural Product Likeliness | 0.169 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.128 |
MDCK | 0.0000316 |
BBB | 0.984 |
PPB | 0.38074 |
VDSS | 0.991 |
FU | 0.757067 |
CYP1A2-inh | 0.856 |
CYP1A2-sub | 0.599 |
CYP2c19-inh | 0.255 |
CYP2c19-sub | 0.87 |
CYP2c9-inh | 0.058 |
CYP2c9-sub | 0.353 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.386 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.284 |
CL | 8.94 |
T12 | 0.709 |
hERG | 0.027 |
Ames | 0.013 |
ROA | 0.029 |
SkinSen | 0.196 |
Carcinogencity | 0.09 |
EI | 0.983 |
Respiratory | 0.177 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.730919 |